Explore how AI accelerates antibody discovery by enabling de novo design, epitope prediction, and in silico affinity maturation for highly specific, developable therapeutics.
Learn how deep learning and structure-based models optimize antibody stability, immunogenicity and target binding to advance precision biologics.
Speaker(s):
Adam Root
Vice President & Head, Protein Sciences
Generate Biomedicines
Time:
3:30 PM - 4:00 PM
Agenda Track No.:
Track 1
Session Type:
General Session (Presentation)